Triggering ovulation with leuprolide acetate (LA) instead of human chorionic gonadotropin (hCG) after the use of ganirelix for in vitro fertilization-embryo transfer (IVF-ET) does not compromise cycle outcome and may prevent ovarian hyperstimulation syndrome.

2001 ◽  
Vol 76 (3) ◽  
pp. S93 ◽  
Author(s):  
N.J Bracero ◽  
M.W Jurema ◽  
M.N Posada ◽  
J.G Whelan ◽  
J.E Garcia ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document